MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer. Barbeau LMO, Beelen NA, Savelkouls KG, Keulers TGH, et al. PLoS One 2025;20:e0316716.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barbeau LMO, Beelen NA, Savelkouls KG, Keulers TGH, et al. MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer. PLoS One 2025;20:e0316716.
PMID: 39928678